(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are NEPI ROCKCASTLE, ASM INTERNATIONAL, and IMMOBEL.

Financial Asset	Price	Change	Updated (EST)
NEPI ROCKCASTLE (NRP.AS)	5.20	8.33%	2023-10-25 12:02:53
ASM INTERNATIONAL (ASM.AS)	390.50	7.81%	2023-10-25 12:00:33
IMMOBEL (IMMO.BR)	27.85	7.12%	2023-10-25 12:20:20
STOREBRAND (STB.OL)	88.30	6.82%	2023-10-25 12:43:34
ABIONYX PHARMA (ABNX.PA)	1.25	5.91%	2023-10-25 12:44:28
MITHRA (MITRA.BR)	1.20	5.62%	2023-10-25 12:20:41
SMARTCRAFT (SMCRT.OL)	22.00	4.76%	2023-10-25 12:43:03
OCEANTEAM (OTS.OL)	1.45	4.71%	2023-10-25 12:41:41
AKER HORIZONS (AKH.OL)	4.54	4.32%	2023-10-25 12:24:23
SEQUANA MEDICAL (SEQUA.BR)	2.71	4.23%	2023-10-25 12:21:20

The three biggest losers today are NORTHERN DRILLING, BIOSENIC, and BERGENBIO.

Financial Asset	Price	Change	Updated (EST)
NORTHERN DRILLING (NODL.OL)	0.95	-17.39%	2023-10-25 12:41:30
BIOSENIC (BIOS.BR)	0.05	-15.79%	2023-10-25 12:05:01
BERGENBIO (BGBIO.OL)	0.15	-13.45%	2023-10-25 12:24:56
LAVIDE HOLDING (LVIDE.AS)	0.20	-9.55%	2023-10-25 12:02:36
BEAULIEU-AV. CERT (BEAB.BR)	3.60	-9.55%	2023-10-25 12:04:51
NYKODE THERAPEUTIC (NYKD.OL)	18.33	-8.81%	2023-10-25 12:41:40
KITRON (KIT.OL)	30.10	-8.65%	2023-10-25 12:40:45
SAS AB (SASNO.OL)	0.04	-8.47%	2023-10-25 12:42:38
NEL (NEL.OL)	6.84	-7.79%	2023-10-25 12:41:18
TECHSTEP (TECH.OL)	8.30	-7.77%	2023-10-25 12:43:41

Winners today

1. NEPI ROCKCASTLE (NRP.AS)

8.33% Price Change

NEPI Rockcastle is the premier owner and operator of shopping centres in Central and Eastern Europe (CEE), with presence in nine countries and an investment portfolio of €5.8 billion as at 31 December 2021. The Group benefits from a highly-skilled internal management team which combines asset management, development, investment, leasing and financial expertise. Geographically diverse management skills allow NEPI Rockcastle to pursue CEE property opportunities efficiently, benefiting from a strategic advantage in the acquisition, development and management of properties. NEPI Rockcastle owns and operates 52 retail properties (excluding joint venture) which attracted 244 million visits in 2021 (325 million visits in 2019). With group-level management of tenant relationships and a focus on cross-country collaboration, the Group is the leading strategic partner for major retailers targeting CEE countries. The Group's financial strategy includes maintaining a profile of adequate liquidity, conservative gearing, and a diverse debt structure, which combines secured and unsecured bank debt with unsecured bonds listed on the Irish Stock Exchange. NEPI Rockcastle is investment-grade rated by Standard & Poor's (BBB, stable outlook) and Fitch (BBB, positive outlook). NEPI Rockcastle's shares are listed on the Johannesburg Stock Exchange (“JSE”), Euronext Amsterdam (“Euronext”) and A2X. The Group voluntarily distributes at least 90% of its distributable earnings on a semi-annual basis.

AEX-Index ended the session with NEPI ROCKCASTLE jumping 8.33% to €5.20 on Wednesday, after two sequential sessions in a row of losses. AEX-Index jumped 0.07% to €722.24, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, NEPI ROCKCASTLE has a trailing twelve months EPS of €0.85.

PE Ratio

NEPI ROCKCASTLE has a trailing twelve months price to earnings ratio of 6.12. Meaning, the purchaser of the share is investing €6.12 for every euro of annual earnings.

More news about NEPI ROCKCASTLE.

2. ASM INTERNATIONAL (ASM.AS)

7.81% Price Change

ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices in the United States, Europe, and Asia. Its products include wafer processing deposition systems for single-wafer atomic layer deposition, plasma enhanced chemical vapor deposition, epitaxy, silicon carbide, vertical furnace systems, and low pressure chemical vapor deposition and diffusion products, as well as provides spare parts and support services. The company also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. It offers its products to semiconductor manufacturers. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.

AEX-Index ended the session with ASM INTERNATIONAL rising 7.81% to €390.50 on Wednesday, following the last session’s downward trend. AEX-Index rose 0.07% to €722.24, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €18.15.

PE Ratio

ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 21.52. Meaning, the purchaser of the share is investing €21.52 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.13%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 28.2% and a negative 5.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 19.6%, now sitting on 2.71B for the twelve trailing months.

More news about ASM INTERNATIONAL.

3. IMMOBEL (IMMO.BR)

7.12% Price Change

Immobel SA engages in the real estate development business in Belgium, Luxemburg, France, Germany, Poland, and Spain. The company undertakes office, residential, and retail projects, as well as develops real estate projects for living, working, and recreational activities. It also provides project management and leasing services. The company was formerly known as Allfin NV and changed its name to Immobel SA in June 2016. The company was incorporated in 1863 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with IMMOBEL rising 7.12% to €27.85 on Wednesday, following the last session’s upward trend. BEL 20 fell 0.78% to €3,314.34, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, IMMOBEL has a trailing twelve months EPS of €-0.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.21%.

Volume

Today’s last reported volume for IMMOBEL is 3798 which is 22.45% below its average volume of 4898.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Apr 24, 2023, the estimated forward annual dividend rate is 3.05 and the estimated forward annual dividend yield is 11.75%.

Volatility

IMMOBEL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.06%, a negative 0.72%, and a positive 1.93%.

IMMOBEL’s highest amplitude of average volatility was 1.94% (last week), 2.53% (last month), and 1.93% (last quarter).

More news about IMMOBEL.

4. STOREBRAND (STB.OL)

6.82% Price Change

Storebrand ASA, through its subsidiaries, primarily provides insurance products and services in Norway, the United States, Japan, and Sweden. The company operates through four segments: Savings, Insurance, Guaranteed Pension, and Other. The Savings segment offers retirement savings, defined contribution pensions, asset management, and retail banking products. The Insurance segment provides health insurance, property and casualty insurance, personal risk products, and employee-related and pension-related insurance products. The Guaranteed Pension segment offers long-term pension savings products, such as defined contribution pensions, paid-up policies, and individual capital and pension insurance products. The Other segment provides life insurance products. The company also offers securities, and banking and investment services. It serves private individuals, corporate and retail markets, companies, municipalities, and public sector. Storebrand ASA was founded in 1767 and is headquartered in Lysaker, Norway. Storebrand ASA operates as a subsidiary of The Storebrand Group.

Oslo Børs Benchmark Index_GI ended the session with STOREBRAND rising 6.82% to €88.30 on Wednesday, after four successive sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 0.45% to €1,259.14, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, STOREBRAND has a trailing twelve months EPS of kr5.82.

PE Ratio

STOREBRAND has a trailing twelve months price to earnings ratio of 15.17. Meaning, the purchaser of the share is investing kr15.17 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.22%.

Moving Average

STOREBRAND’s value is above its 50-day moving average of kr85.35 and higher than its 200-day moving average of kr83.80.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, STOREBRAND’s stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 25.2% and 9.2%, respectively.

More news about STOREBRAND.

5. ABIONYX PHARMA (ABNX.PA)

5.91% Price Change

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.

CAC 40 ended the session with ABIONYX PHARMA jumping 5.91% to €1.25 on Wednesday, after four sequential sessions in a row of losses. CAC 40 jumped 0.31% to €6,915.07, after two successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.14.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABIONYX PHARMA’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

ABIONYX PHARMA’s stock is valued at €1.25 at 22:40 EST, way below its 52-week high of €2.49 and way higher than its 52-week low of €1.11.

Volume

Today’s last reported volume for ABIONYX PHARMA is 354658 which is 369.05% above its average volume of 75611.

Moving Average

ABIONYX PHARMA’s worth is under its 50-day moving average of €1.28 and way below its 200-day moving average of €1.74.

More news about ABIONYX PHARMA.

6. MITHRA (MITRA.BR)

5.62% Price Change

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.

BEL 20 ended the session with MITHRA rising 5.62% to €1.20 on Wednesday, following the last session’s downward trend. BEL 20 dropped 0.78% to €3,314.34, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, MITHRA has a trailing twelve months EPS of €-1.41.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -575.59%.

Volume

Today’s last reported volume for MITHRA is 66539 which is 81.39% below its average volume of 357598.

Moving Average

MITHRA’s value is way below its 50-day moving average of €1.85 and way below its 200-day moving average of €2.44.

Revenue Growth

Year-on-year quarterly revenue growth declined by 38.1%, now sitting on 62.67M for the twelve trailing months.

More news about MITHRA.

7. SMARTCRAFT (SMCRT.OL)

4.76% Price Change

SmartCraft ASA provides software solutions to the construction industry in Norway, Sweden, and Finland. The company offers Cordel; Bygglet, a SaaS born in the cloud solution; EL-VIS, a solution for electricians; and Congrid, a cloud-based tool for project management in construction companies. It also provides HomeRun, a digital tool for construction, project communication, document, and procurement management; Kvalitetskontroll, a cloud-based project management solution and quality assurance platform for construction companies; El-verdi, a digital sales tool for electricians; and ELinn, a cloud based solution for electricians to handle project management services. The company was founded in 1987 and is headquartered in Hønefoss, Norway.

Oslo Børs Benchmark Index_GI ended the session with SMARTCRAFT jumping 4.76% to €22.00 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.45% to €1,259.14.

Earnings Per Share

As for profitability, SMARTCRAFT has a trailing twelve months EPS of kr0.53.

PE Ratio

SMARTCRAFT has a trailing twelve months price to earnings ratio of 41.51. Meaning, the purchaser of the share is investing kr41.51 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.51%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SMARTCRAFT’s stock is considered to be overbought (>=80).

Volatility

SMARTCRAFT’s last week, last month’s, and last quarter’s current intraday variation average was 0.38%, 0.23%, and 2.47%.

SMARTCRAFT’s highest amplitude of average volatility was 3.22% (last week), 2.05% (last month), and 2.47% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 66.7% and 185.7%, respectively.

More news about SMARTCRAFT.

8. OCEANTEAM (OTS.OL)

4.71% Price Change

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 4.71% to €1.45 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI fell 0.45% to €1,259.14, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.33.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.62%.

Moving Average

OCEANTEAM’s worth is way under its 50-day moving average of kr1.61 and under its 200-day moving average of kr1.58.

More news about OCEANTEAM.

9. AKER HORIZONS (AKH.OL)

4.32% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in a portfolio of companies in the renewable energy and green technology comprising private and public companies worldwide. It sources, develops, structures, builds, and operates wind and solar power assets; and develops, builds, owns, and operates clean hydrogen production at industrial scale. The company also provides products, technology, and solutions within the field of carbon capture, utilization, and storage. In addition, it offers products and services to the hydropower industry; designs and delivers superconducting systems; and produces silicon materials. The company was incorporated in 2020 and is headquartered in Lysaker, Norway. Aker Horizons ASA operates as a subsidiary of Aker Capital AS.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS rising 4.32% to €4.54 on Wednesday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.45% to €1,259.14, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-9.91.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 60.8%, now sitting on 3B for the twelve trailing months.

More news about AKER HORIZONS.

10. SEQUANA MEDICAL (SEQUA.BR)

4.23% Price Change

Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL rising 4.23% to €2.71 on Wednesday, after two sequential sessions in a row of losses. BEL 20 fell 0.78% to €3,314.34, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -690.43%.

Moving Average

SEQUANA MEDICAL’s worth is way below its 50-day moving average of €3.23 and way under its 200-day moving average of €4.00.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SEQUANA MEDICAL’s stock is considered to be overbought (>=80).

More news about SEQUANA MEDICAL.

Losers Today

1. NORTHERN DRILLING (NODL.OL)

-17.39% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING dropping 17.39% to €0.95 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 0.45% to €1,259.14, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-6.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

More news about NORTHERN DRILLING.

2. BIOSENIC (BIOS.BR)

-15.79% Price Change

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with BIOSENIC falling 15.79% to €0.05 on Wednesday while BEL 20 dropped 0.78% to €3,314.34.

Earnings Per Share

As for profitability, BIOSENIC has a trailing twelve months EPS of €7.53.

PE Ratio

BIOSENIC has a trailing twelve months price to earnings ratio of 0.01. Meaning, the purchaser of the share is investing €0.01 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BIOSENIC’s stock is considered to be overbought (>=80).

More news about BIOSENIC.

3. BERGENBIO (BGBIO.OL)

-13.45% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO falling 13.45% to €0.15 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.45% to €1,259.14.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-1.65.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Volume

Today’s last reported volume for BERGENBIO is 178517000 which is 166.17% above its average volume of 67067100.

Moving Average

BERGENBIO’s value is way above its 50-day moving average of kr0.13 and way under its 200-day moving average of kr4.18.

Volatility

BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.96%, a positive 2.36%, and a positive 6.35%.

BERGENBIO’s highest amplitude of average volatility was 14.15% (last week), 7.67% (last month), and 6.35% (last quarter).

More news about BERGENBIO.

4. LAVIDE HOLDING (LVIDE.AS)

-9.55% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING sliding 9.55% to €0.20 on Wednesday, after five successive sessions in a row of losses. AEX-Index jumped 0.07% to €722.24, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.02.

Volume

Today’s last reported volume for LAVIDE HOLDING is 3 which is 99.91% below its average volume of 3506.

Yearly Top and Bottom Value

LAVIDE HOLDING’s stock is valued at €0.20 at 22:40 EST, way below its 52-week high of €0.51 and way above its 52-week low of €0.14.

More news about LAVIDE HOLDING.

5. BEAULIEU-AV. CERT (BEAB.BR)

-9.55% Price Change

Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with BEAULIEU-AV. CERT sliding 9.55% to €3.60 on Wednesday while BEL 20 dropped 0.78% to €3,314.34.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BEAULIEU-AV. CERT’s stock is considered to be oversold (<=20).

Volatility

BEAULIEU-AV. CERT’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.91%, a negative 1.36%, and a positive 10.04%.

BEAULIEU-AV. CERT’s highest amplitude of average volatility was 10.28% (last week), 11.73% (last month), and 10.04% (last quarter).

More news about BEAULIEU-AV. CERT.

6. NYKODE THERAPEUTIC (NYKD.OL)

-8.81% Price Change

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for COVID-19 T cell vaccine development; and research agreement with Regeneron. The company was formerly known as Vaccibody AS. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NYKODE THERAPEUTIC dropping 8.81% to €18.33 on Wednesday while Oslo Børs Benchmark Index_GI fell 0.45% to €1,259.14.

Earnings Per Share

As for profitability, NYKODE THERAPEUTIC has a trailing twelve months EPS of kr-1.88.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.1%.

More news about NYKODE THERAPEUTIC.

7. KITRON (KIT.OL)

-8.65% Price Change

Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, rest of Europe, the United States, and internationally. It manufactures electronics that are embedded in the customers' products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. Its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. The company was incorporated in 1996 and is headquartered in Billingstad, Norway.

Oslo Børs Benchmark Index_GI ended the session with KITRON falling 8.65% to €30.10 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.45% to €1,259.14, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, KITRON has a trailing twelve months EPS of kr2.65.

PE Ratio

KITRON has a trailing twelve months price to earnings ratio of 11.36. Meaning, the purchaser of the share is investing kr11.36 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.51%.

Volatility

KITRON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.34%, a negative 0.29%, and a positive 1.67%.

KITRON’s highest amplitude of average volatility was 2.15% (last week), 2.20% (last month), and 1.67% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

KITRON’s EBITDA is 435.84.

Moving Average

KITRON’s worth is way below its 50-day moving average of kr36.71 and way under its 200-day moving average of kr36.31.

Sales Growth

KITRON’s sales growth is 21.3% for the ongoing quarter and 18.2% for the next.

More news about KITRON.

8. SAS AB (SASNO.OL)

-8.47% Price Change

SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 135 aircraft, including 12 long-haul aircraft, 95 short-haul aircraft, and 28 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Oslo Børs Benchmark Index_GI ended the session with SAS AB sliding 8.47% to €0.04 on Wednesday, after three consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI fell 0.45% to €1,259.14, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, SAS AB has a trailing twelve months EPS of kr-0.7.

Revenue Growth

Year-on-year quarterly revenue growth grew by 53.5%, now sitting on 40.68B for the twelve trailing months.

More news about SAS AB.

9. NEL (NEL.OL)

-7.79% Price Change

Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment produces H2Station hydrogen fueling stations that provide fuel cell electric vehicles with the fueling and long range as conventional fossil fuel vehicles, include cars, buses, trucks, and other applications. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industry, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEL falling 7.79% to €6.84 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI fell 0.45% to €1,259.14, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, NEL has a trailing twelve months EPS of kr-0.96.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.44%.

More news about NEL.

10. TECHSTEP (TECH.OL)

-7.77% Price Change

Techstep ASA operates as a mobile technology enabler in Norway, Sweden, Denmark, and Poland. It offers mobile hardware, service, support, and mobility consultancy services; software as a service, as well as mobile expense management modules; and financing and remarketing services. The company also provides enterprise mobility management services, including mobile security, system design, implementation, and mobile device management. In addition, it develops and provides enterprise mobility software and solutions for the customers in the transportation, logistics, and public safety sectors, as well as offers mobile device lifecycle management solutions. The company was founded in 2016 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with TECHSTEP sliding 7.77% to €8.30 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI fell 0.45% to €1,259.14, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, TECHSTEP has a trailing twelve months EPS of kr-2.52.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.38%.

Volatility

TECHSTEP’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.11%, a negative 0.80%, and a positive 2.67%.

TECHSTEP’s highest amplitude of average volatility was 3.88% (last week), 3.98% (last month), and 2.67% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 8.1%, now sitting on 1.24B for the twelve trailing months.

More news about TECHSTEP.

Stay up to date with our winners and losers daily report